GUIDA, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 8.354
NA - Nord America 6.311
AS - Asia 2.765
SA - Sud America 741
AF - Africa 83
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.269
Nazione #
IT - Italia 6.216
US - Stati Uniti d'America 6.209
SG - Singapore 1.255
CN - Cina 709
BR - Brasile 634
HK - Hong Kong 383
SE - Svezia 380
RU - Federazione Russa 307
NL - Olanda 261
UA - Ucraina 256
DE - Germania 250
GB - Regno Unito 176
VN - Vietnam 173
FI - Finlandia 163
FR - Francia 107
CA - Canada 46
PL - Polonia 46
IN - India 44
AR - Argentina 39
BE - Belgio 34
MX - Messico 33
TR - Turchia 28
ID - Indonesia 27
ZA - Sudafrica 27
ES - Italia 26
BD - Bangladesh 25
CI - Costa d'Avorio 25
CH - Svizzera 23
JP - Giappone 22
AT - Austria 20
PK - Pakistan 17
IE - Irlanda 16
EC - Ecuador 13
IR - Iran 12
CZ - Repubblica Ceca 11
VE - Venezuela 11
AL - Albania 10
AU - Australia 10
CO - Colombia 10
IQ - Iraq 10
PY - Paraguay 9
JO - Giordania 8
LT - Lituania 8
MA - Marocco 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
CL - Cile 6
TN - Tunisia 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
HR - Croazia 5
KZ - Kazakistan 5
LU - Lussemburgo 5
PE - Perù 5
UY - Uruguay 5
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
JM - Giamaica 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
BW - Botswana 3
CR - Costa Rica 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
KE - Kenya 3
NO - Norvegia 3
NP - Nepal 3
SA - Arabia Saudita 3
TW - Taiwan 3
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
KR - Corea 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SR - Suriname 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DM - Dominica 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
Totale 18.263
Città #
Chandler 662
Singapore 658
Rome 535
Fairfield 519
Ashburn 504
Jacksonville 504
Woodbridge 485
Hong Kong 382
Ann Arbor 316
Milan 285
Nyköping 259
Houston 243
Bari 230
Cambridge 222
Seattle 204
Beijing 188
Wilmington 185
Naples 158
New York 138
Lawrence 131
Roxbury 131
Nanjing 128
Bologna 109
Los Angeles 103
Catania 87
Boardman 84
Dallas 83
Des Moines 83
Inglewood 83
Florence 66
São Paulo 59
Napoli 57
Ho Chi Minh City 55
Princeton 51
Padova 46
Turin 42
Brooklyn 39
Taranto 37
Buffalo 34
Parma 34
Helsinki 33
Munich 33
Nanchang 31
Hebei 30
Santa Clara 30
Dong Ket 29
Brussels 28
Tianjin 28
Dearborn 27
London 27
Abidjan 25
Hanoi 25
Palermo 25
Nuremberg 24
Rio de Janeiro 24
San Diego 24
Torino 24
Jakarta 23
Lucca 23
Perugia 23
Warsaw 23
Belo Horizonte 22
Jiaxing 22
Messina 22
Salerno 22
Pescara 21
Tokyo 21
Cagliari 20
Caserta 20
Pisa 20
Shenyang 20
Verona 20
Brescia 19
Ferrara 18
Genoa 18
Changsha 17
Johannesburg 17
Redwood City 17
San Francisco 17
Denver 16
Latina 16
Mottola 16
Stockholm 16
Toronto 16
Council Bluffs 15
Guangzhou 15
Montreal 15
Reggio Calabria 15
Chicago 14
Manchester 14
Turku 14
Vienna 14
Atlanta 13
Dublin 13
Aversa 12
Moscow 12
Shanghai 12
Vicenza 12
Augusta 11
Jinan 11
Totale 9.423
Nome #
FOSFORILAZIONE DEL FATTORE DI INIZIO DELLA TRADUZIONE eIF2 IN LINEE CELLULARI DI MELANOMA 6.655
New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations. 199
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells 177
Influence of melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of patients with metastatic melanoma harboring the BRAF mutation and treated with BRAF inhibitors 176
Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants 170
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy 168
Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α 162
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors 156
ANALISI MOLECOLARE E FUNZIONALE DEL RECETTORE MC1R NEL MELANOMA MALIGNO 154
MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors 147
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale) 135
Metastatic melanoma cells with BRAF G469A mutation: nab‑paclitaxel better than vemurafenib? 134
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project 130
NEW HORIZONS IN TREATMENTS OF METASTATIC MELANOMA: THE ROLE OF TOMATINE 126
Amphibian Kupffer Cells: TyrosinaseGene Expression 122
Barasertib: a novel approach for the treatment of metastatic melanoma 122
ACTIVATION OF DETOXIFYING ENZYMES IN TOMATO ROOTS FOLLOWING PARAQUAT TREATMENT AND NEMATODE INFECTION 118
Three novel human sporadic melanoma cell lines: signaling pathways controlled by MC1R, BRAF and β-catenins 118
MC1R genotype and psoriasis: is there a link revealing a phenotypic differences? 118
Seasonal variations of Rana esculenta L. skin tyrosinase 117
Negative influence of Melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of metastatic melanoma (MM) patients (pts) harboring BRAF mutation and treated with BRAF inhibitors (BRAFi) 116
Spleen and liver pigmented macrophages of Rana esculenta L.A new melanogenic system? 114
The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma 114
CARATTERIZZAZIONE DEL SISTEMA MELANOGENETICO DEI MELANOMACROFAGI 113
Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib 112
Molecular and Ultrastructural analysis of a multiphasic oral malignant Melanoma 111
The translation initiation factor eIF2 is hyperphosphorylated in melanoma cell lines 110
ULTRASTRUCTURE OF THE CELL WALL OF GRACILARIA C.F. VERRUCOSA (GRACILARIALES, RHODOPHYTA): EFFECTS OF STEAM EXPLOSION 109
Metabolic reprogramming in melanoma: the role of peIF2 alpha 109
A NOVEL APPROACH FOR THE TREATMENT OF METASTATIC MELANOMA 107
Analysis of the enzymatic activity of the pigmented macrophages from liver and spleen of Rana esculenta L. 107
INCREASE IN RNA AND PROTEIN SYNTHESIS BY MITOCHONDRIA IRRADIATED WITH HELIUM-NEON LASER 106
The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational status 106
The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational status. 105
Genetic profiling of a rare condition: Co-occurrence of albinism and multiple primary melanoma in a caucasian family 104
Tyrosinase gene expression in the Kupffer Cells of Rana esculentaL 102
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort 100
Effects of alpha-MSH on the tyrosinase system in Kupffer cells of Rana esulenta L 98
CARATTERIZZAZIONE DEL SISTEMA MELANOGENETICO CUTANEO DI RANA ESCULENTA L 98
THE INFLUENCE OF MC1R DERMAL MORPHOLOGICAL FEATURES OF PHOTOEXPOSED SKIN IN WOMEN REVEALED BY REFLECTANCE CONFOCAL MICROSCOPY AND OPTICAL COHERENCE TOMOGRAPHY 98
CHARACTERIZATION OF THE SKIN MELANOGENETIC SYSTEM OF RANA ESCULENTA L 97
MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project 97
The next generation of metastatic melanoma: Uncovering the genetic variants for anti-BRAF therapy response 96
ACTIVATION OF DETOXIFYING ENZYMES IN TOMATO ROOTS FOLLOWING PARAQUAT TREATMENT AND NEMATODE INFECTION. NEMATOLOGIA MEDITERRANEA 96
Analisi delle attività enzimatiche dei melanosomi isolati dai macrofagi pigmentati di Rana esculenta L. 94
Attività Tirosinasica delle Cellule di Kupffer di Rana esculenta L. 94
CARATTERIZZAZIONE DEL SISTEMA MELANOGENETICO DEI MELANOMACROFAGI 94
ATTIVITA' TIROSINASICA DELLE CELLULE DI KUPFFER DI RANA ESCULENTA L 93
Aspetti molecolari della proliferazione cellulare e della metastatizzazione nel melanoma 92
Amphibian Kupffer Cells: Tyrosinase Gene Expression. 92
Characterization of the melanogenic system in the SHK-1 cell line from Salmo salar L. Atlantic salmon 91
Stress response pathways driving tumorigenesis in melanoma cell lines. 91
Analysis of the enzymatic activity of the pigmented macrophages from liver and spleen of Rana esculenta L 91
Kupffer cell response to MSH in Rana esculenta L. 90
Molecular cloning and biochemical characterization of the skin tyrosinase from Rana esculenta L 90
Caratterizzazione del sistema melanogenetico dei melanomacrofagi epatici di Rana esculenta L. 89
Analisi delle attività enzimatiche dei melanosomi isolati dai macrofagi pigmentati di Rana esculenta L 86
STUDIES ON PIGMENT CELLS FROM THE LIVER OF RANA ESCULENTA L 86
Phosphorilated ERK and eIF2alpha levels in melanoma cells. 86
ANALISI MOLECOLARE E FUNZIONALE DEL RECETTORE MC1R NEL MELANOMA MALIGNO 85
EXPRESSION OF BASE EXCISION REPAIR KEY FACTORS AND miR17 IN FAMILIAL AND SPORADIC BREAST CANCER. 85
PGC1 alpha expression and correlation with BRAF mutational status 84
Analisi del sistema tirosinasico nella linea cellulare SHK-1 di Salmo Salar L. (Teleostei) 83
Characterization of the skin tyrosinase from Rana esculenta L 82
Optical spectroscopy of melanin films. 82
Melanogenic response of the Kupffer cells of Rana esculenta L to melanocyte stimulating hormone 82
Morphological and molecular characterization of a heterogeneous melanoma of the oral cavity 81
Correlazione tra stato mutazionale di MC1R ed outcomes clinici in pazienti (pts) affetti da melanoma metastaticoBRAF-mutati (MM) trattati con farmaci anti-BRAF 81
HELIUM-NEON LASER IRRADIATION OF RAT LIVER MITOCHONDRIA GIVES RISE TO A NEW SUBPOPULATION OF MITOCHONDRIA: ISOLATION AND FIRST BIOCHEMICAL CHARACTERIZATION 81
Tomatine displays antitumor potential in in vitro models of metastatic melanoma 81
Optical and photoelectronic properties of Melanin Films. 80
Control of tyrosinase gene activation by 80
Optical spectra of melanin films extracted from Rana Esculenta 79
High activity of the Aurora B Kinase inhibitor AZD1152 on melanoma cell lines irrespective of BRAF mutation. 79
Kupffer cell response to MSH in Rana esculenta L 78
CHARACTERIZATION OF THE SKIN MELANOGENETIC SYSTEM OF RANA ESCULENTA L 78
Optical Spectra of Melanin Films Extracted from Rana esculenta L 77
Analisi del sistema tirosinasico nella linea cellulare SHK-1 di Salmo Salar L. (Teleostei) 77
Raman and optical spectroscopy of eumelanin films 77
PRELIMINARY EVALUATION OF AN AGAR FRACTION OBTAINED FROM GRACILARIA VERRUCOSA 76
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 75
Control of tyrosinase gene activation by - MSH in Kupffer cells of Rana esculenta L. 75
PGC1 alpha EXPRESSION AND CORRELATION WITH BRAF MUTATIONAL STATUS 75
“Differentiation in vitro of the hepatic pigment cells from Rana esculenta L. 74
Molecular characterization of novel melanoma cell lines 73
THE MELANOGENIC SYSTEM OF THE LIVER PIGMENTED MACROPHAGES OF RANA ESCULENTA L. TYROSINASE ACTIVITY 73
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma 72
Characterization of the Skin Tyrosinase from Rana esculenta L. 71
null 70
Enhanced Delivery of 5‑Aminolevulinic Acid by Lecithin Invasomes in 3D Melanoma Cancer Model 67
Studio sulle cellule pigmentate di origine istiocitaria di Rana esculenta L. Espressione in vitro del gene della tirosinasi 67
Studio sui processi di proliferazione cellulare e metastatizzazione in nuove linee cellulari di melanoma. 66
MOLECULAR AND FUNCTIONAL ANALYSIS OF MC1R RECEPTOR IN MALIGNANT MELANOMA 66
MC1R RECEPTOR IN MALIGNANT MELANOMA: MOLECULAR AND FUNCTIONAL ANALYSIS 66
Characterization of the tyrosinase enzyme of pigment cells from Rana esculenta L. liver 65
Profilo proteomico di pazienti BRAF wild type trattati con temozolomide 64
Geni di suscettibilità del melanoma: revisione ed update 63
null 62
OPTICAL SPETTROSCOPY OF MELANIN FILMS 61
STUDIO SULLA REGOLAZIONE DELLA MELANOGENESI NEI MACROFAGI PIGMENTATIEPATICI DI RANA ESCULENTA L 61
Totale 16.342
Categoria #
all - tutte 58.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.114 0 0 0 0 0 106 265 107 168 185 155 128
2021/20221.377 68 135 43 41 83 125 80 84 98 80 217 323
2022/20232.381 251 176 138 216 259 232 153 313 349 55 93 146
2023/20241.614 123 129 90 68 106 235 263 208 71 91 85 145
2024/20253.460 260 80 290 139 204 322 382 310 169 158 459 687
2025/20263.003 698 329 337 743 783 113 0 0 0 0 0 0
Totale 18.683